Not sure what the rest of you think, but for me this conference call is nothing but more stalling.
Lots of nebulous dates, soft data and efforts with no tangible results.
What people are not saying is that the data for CD10,the Montefiore studies, etc has not satisfied the FDA because they are dragging their heels until their Big Pharma masters can catch up with their MABs.
Freaking disgusting the amount of noise in this process. I wonder if the FDA be the target of class action suits by investors?